Ambien CR News
Ahead of the Bell: Par Pharma Downgraded - Forbes
... company to file applications for generic versions of several drugs in 2009, including attention-deficit medication Ritalin LA and sleep aid Ambien CR. ...
Neurogen Announces R&D Update - PharmaLive.com (press release)
For insomnia, we intend to run adipiplon side-by-side with Ambien CR in a crossover study designed to further define the clinical and commercial profile of ...
Ahead of the Bell: Par Pharma Downgraded - Houston Chronicle
... company to file applications for generic versions of several drugs in 2009, including attention-deficit medication Ritalin LA and sleep aid Ambien CR. ...
InterCure Wins Hitwise US Top 10 Award for Q4 2007 - Biloxi Sun Herald
Additional websites recognized by Hitwise in the same category include a number of established health brands such as Merck, Ambien CR, Alli, Viagra, ...
Sepracor Inc. Reports 2007 Fourth Quarter and Full-Year Results ... - WELT ONLINE
Ambien CR is a registered trademark of sanofi-aventis. In conjunction with this Fourth Quarter and Full-Year 2007 Financial Results press release, ...
Long, misleading Clemens report to bore Congress - Stamford Advocate
... drugs Clemens has admitted to taking, it is available on the Internet without a prescription and is much cheaper and safer than Lunesta or Ambien CR. ...
NovaDel's New Drug Application For ZolpiMist Oral Spray To Treat ... - Medical News Today (press release)
Ambien®/Ambien CR™ (zolpidem tartrate) and generic zolpidem tartrate are the dominant prescription drugs totaling more than 70% of the market in 2006. ...
Long, misleading report a bore to Congress - Newsday
... drugs Clemens has admitted to taking, it is available on the Internet without a prescription and is much cheaper and safer than Lunesta or Ambien CR. ...
Sanofi Aventis FY earnings growth hits target, sees EPS up 7 pct ... - Forbes
Ambien sales in the fourth quarter alone fell 64.6 pct due to the launch of generic competitors in the US last April. Ambien CR, a new version of the drug, ...
Sanofi Aventis FY earnings growth hits target, sees EPS up 7 pct ... - CNNMoney.com
Ambien sales in the fourth quarter alone fell 64.6 pct due to the launch of generic competitors in the US last April. Ambien CR, a new version of the drug, ...
Ambien CR RSS Feed